MIB2 and non-small cell lung carcinoma: Collectively, our study revealed that MIB2 promoted the occurrence of lung cancer by regulating cell cycle, which may help to promote the development of new diagnostic or therapeutic biomarker to improve the prognosis of patients with NSCLC.